Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Understanding and overcoming aminoglycoside resistance caused by N-6'-acetyltransferase.

Vong K, Auclair K.

Medchemcomm. 2012 Apr 1;3(4):397-407. doi: 10.1039/C2MD00253A.

2.

Diastereomeric bactericidal effect of Ru(phenanthroline)2 dipyridophenazine.

Mårtensson AK, Bergentall M, Tremaroli V, Lincoln P.

Chirality. 2016 Nov;28(11):713-720. doi: 10.1002/chir.22656.

3.

Antibiotic dialogues: induction of silent biosynthetic gene clusters by exogenous small molecules.

Okada BK, Seyedsayamdost MR.

FEMS Microbiol Rev. 2017 Jan;41(1):19-33. doi: 10.1093/femsre/fuw035. Epub 2016 Aug 29. Review.

PMID:
27576366
4.

Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.

Outterson K, Gopinathan U, Clift C, So AD, Morel CM, Røttingen JA.

PLoS Med. 2016 Jun 14;13(6):e1002043. doi: 10.1371/journal.pmed.1002043. eCollection 2016 Jun.

5.

Are good intentions putting the vaccination ecosystem at risk?

Watson M, Faron de Goër E.

Hum Vaccin Immunother. 2016 Sep;12(9):2469-74. doi: 10.1080/21645515.2016.1172162. Epub 2016 Jun 6.

6.

The oxadiazole antibacterials.

Janardhanan J, Chang M, Mobashery S.

Curr Opin Microbiol. 2016 Oct;33:13-17. doi: 10.1016/j.mib.2016.05.009. Epub 2016 May 27. Review.

PMID:
27239942
7.

Bioprospecting Sponge-Associated Microbes for Antimicrobial Compounds.

Indraningrat AA, Smidt H, Sipkema D.

Mar Drugs. 2016 May 2;14(5). pii: E87. doi: 10.3390/md14050087. Review.

8.

Synthesis, Antibacterial Evaluation and QSAR of α-Substituted-N₄-Acetamides of Ciprofloxacin and Norfloxacin.

Qandil AM, Al-Zoubi LO, Al-Bakri AG, Amawi HA, Al-Balas QA, Alkatheri AM, Albekairy AM.

Antibiotics (Basel). 2014 Jun 25;3(3):244-69. doi: 10.3390/antibiotics3030244.

9.

In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents.

Czyzewski AM, Jenssen H, Fjell CD, Waldbrook M, Chongsiriwatana NP, Yuen E, Hancock RE, Barron AE.

PLoS One. 2016 Feb 5;11(2):e0135961. doi: 10.1371/journal.pone.0135961. eCollection 2016.

10.

A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics.

Renwick MJ, Brogan DM, Mossialos E.

J Antibiot (Tokyo). 2016 Feb;69(2):73-88. doi: 10.1038/ja.2015.98. Epub 2015 Oct 14. Review.

11.

Public funding of clinical-stage antibiotic development in the United States and European Union.

Eichberg MJ.

Health Secur. 2015 May-Jun;13(3):156-65. doi: 10.1089/hs.2014.0081.

12.

Challenges and solutions for clinical development of new antibacterial agents: results of a survey among pharmaceutical industry professionals.

Bettiol E, Wetherington JD, Schmitt N, Harbarth S; COMBACTE Consortium.

Antimicrob Agents Chemother. 2015 Jul;59(7):3695-9. doi: 10.1128/AAC.00638-15. Epub 2015 Apr 27.

13.

Bacterial temporal dynamics enable optimal design of antibiotic treatment.

Meredith HR, Lopatkin AJ, Anderson DJ, You L.

PLoS Comput Biol. 2015 Apr 23;11(4):e1004201. doi: 10.1371/journal.pcbi.1004201. eCollection 2015 Apr.

14.

Collective antibiotic tolerance: mechanisms, dynamics and intervention.

Meredith HR, Srimani JK, Lee AJ, Lopatkin AJ, You L.

Nat Chem Biol. 2015 Mar;11(3):182-8. doi: 10.1038/nchembio.1754. Epub 2015 Feb 17. Review.

15.

Statistical research on the bioactivity of new marine natural products discovered during the 28 years from 1985 to 2012.

Hu Y, Chen J, Hu G, Yu J, Zhu X, Lin Y, Chen S, Yuan J.

Mar Drugs. 2015 Jan 7;13(1):202-21. doi: 10.3390/md13010202.

16.

The bacterial type III secretion system as a target for developing new antibiotics.

McShan AC, De Guzman RN.

Chem Biol Drug Des. 2015 Jan;85(1):30-42. doi: 10.1111/cbdd.12422.

17.

Machine-learning techniques applied to antibacterial drug discovery.

Durrant JD, Amaro RE.

Chem Biol Drug Des. 2015 Jan;85(1):14-21. doi: 10.1111/cbdd.12423.

18.

Cost-effectiveness and pricing of antibacterial drugs.

Verhoef TI, Morris S.

Chem Biol Drug Des. 2015 Jan;85(1):4-13. doi: 10.1111/cbdd.12417.

19.

Enhancing US-Japan cooperation to combat antimicrobial resistance.

Gerbin CS.

Biosecur Bioterror. 2014 Nov-Dec;12(6):337-45. doi: 10.1089/bsp.2014.0034.

20.

Crystallographic and molecular dynamics simulation analysis of Escherichia coli dihydroneopterin aldolase.

Blaszczyk J, Lu Z, Li Y, Yan H, Ji X.

Cell Biosci. 2014 Sep 2;4(1):52. doi: 10.1186/2045-3701-4-52. eCollection 2014.

Supplemental Content

Support Center